Most of the enrolled patients were pathologically diagnosed with invasive ductal carcinoma (IDC), HR-positive (65.80%), and lymphovascular invasion (61.00%), and 420 (84.00%) patients had a Ki-67 index value ≥ 14. The gene discussed is MKI67; the disease is invasive ductal breast carcinoma.